San Diego, CA – September 27, 2016- Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Channing Hamlet, one of its Managing Directors, will be a guest panelist speaker at the Association for Corporate Growth (ACG) San Diego meeting to be held on Tuesday, October 18, 2016. Mr. Hamlet will be joined by fellow panelists Steve Moon, Managing Director of Duff & Phelps Securities, John Henberger, Jr., President of Henberger Group and Jeremiah Mann, Managing Director of Intrepid Investment Bankers. The panel will be moderated by Bill Lynch, VP of ProFinance, and will address the important topic of How Investment Bankers Increase Company Sale Value. A separate breakout session will be conducted after the program specifically for C-Level executives and business owners to allow them to ask questions of the panelists and speakers. The event is sponsored by BDO, Procopio and Vantage Point and will be held at Lomas Santa Fe Country Club in Solana Beach, CA from 7-9 AM. Breakfast is provided with registration for the event.(more…)
By Channing Hamlet
Managing Director, Objective Capital Partners
For business owners to truly assess the potential value of their business, they must first understand what drives business value in their industry. While at a very high level one can use metrics like Enterprise Value (EV)/Revenue or Enterprise Value (EV)/ EBITDA multiples to assess rough hypothetical values, the reality is that each industry has a unique valuation metric that is used to assess businesses that operate in a particular space or sector. Additionally, there are a number of factors besides just growth and profitability that drive significant value.
Successful business owners and leaders create, understand and track specific metrics that increase the value of their business. This article was written to assist you in defining the things to think about in order to manage and grow the value of your business.(more…)
San Diego, CA – September 14, 2016- Objective Capital Partners is pleased to announce that Trever Acers, one of its Managing Directors, will be a guest speaker in a fireside chat alongside Bob Nascenzi to address important topics in the exit of a business on October 5, 2016. The event is sponsored by MIT Enterprise Forum San Diego and will be held a National University, Sanford Center in La Jolla, CA from 5-7 PM.(more…)
Following Positive Results in Phase IIa Heart Failure Clinical Trial,
CardioCell Chooses Objective Capital to Help Manage Rapid Growth
SAN DIEGO – Sept. 7, 2016 – Objective Capital Partners, a leading middle market investment bank and mergers and acquisition (M&A) advisory firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that it has recently been retained by CardioCell LLC to help manage its growth needs. CardioCell, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, recently announced positive data from its Phase IIa clinical trial “Safety and Efficacy of Intravenous Infusion of Ischemia-Tolerant Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Cardiomyopathy” at the European Society of Cardiology (ESC) Congress and is currently planning a Phase III study in early 2017.(more…)
San Diego, CA, September 2, 2016 – Objective Capital Partners, a leading middle market Mergers & Acquisition (MA&) advisory firm focused on transactions for companies with enterprise values up to $500 million, has been announced as a finalist for the 15th Annual M&A Advisor Awards. M&A Advisor recognized Objective Capital Partners’ advisory of Del Mar Recovery Services for the Private Equity Deal of the Year ($25-50MM) award category. Objective Capital served as exclusive financial advisor to Del Mar in its recapitalization with the private equity firm TZP Growth Partners in July 2016.(more…)
This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.